Press coverage about China BAK Battery (NASDAQ:CBAK) has trended somewhat negative recently, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. China BAK Battery earned a media sentiment score of -0.05 on Accern’s scale. Accern also assigned media headlines about the electronics maker an impact score of 45.585467202973 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

China BAK Battery (CBAK) traded up 8.33% during midday trading on Wednesday, hitting $1.95. The company had a trading volume of 71,010 shares. The firm’s 50 day moving average is $1.72 and its 200-day moving average is $1.47. China BAK Battery has a 52 week low of $1.20 and a 52 week high of $2.35. The firm’s market capitalization is $51.13 million.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at

China BAK Battery Company Profile

CBAK Energy Technology, Inc, formerly China BAK Battery, Inc, is a holding company. The Company and its subsidiaries are engaged in the manufacture, commercialization and distribution of a range of standard and customized lithium ion (Li-ion) rechargeable batteries for use in an array of applications.

Insider Buying and Selling by Quarter for China BAK Battery (NASDAQ:CBAK)

Receive News & Ratings for China BAK Battery Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China BAK Battery Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.